• Exchange: Natl India
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharmaceuticals

Aurobindo Pharma Ltd

+ Add to Watchlist


551.00 INR 3.20 0.58%

As of 07:05:37 ET on 04/17/2014.

Snapshot for Aurobindo Pharma Ltd (ARBP)

Open: 545.70 Day's Range: 527.85 - 556.05 Volume: 4,090,859
Previous Close: 547.80 52wk Range: 138.35 - 575.95 1-Yr Rtn: +205.95%

Stock Chart for ARBP

No chart data available.
  • ARBP:IN 551.00
  • 1D
  • 1M
  • 1Y
Interactive ARBP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ARBP

Current P/E Ratio (ttm) 54.5903
Estimated P/E(03/2014) 13.8123
Relative P/E vs. SENSEX 3.1225
Earnings Per Share (INR) (ttm) 10.0934
Est. EPS (INR) (03/2014) 39.8920
Est. PEG Ratio 0.3536
Market Cap (M INR) 160,592.82
Shares Outstanding (M) 291.46
30 Day Average Volume 3,271,207
Price/Book (mrq) 6.1578
Price/Sale (ttm) 2.7397
Dividend Indicated Gross Yield 0.23%
Cash Dividend (INR) 1.2500
Dividend Ex-Date 11/19/2013
5 Year Dividend Growth 7.84%
Next Earnings Announcement 05/30/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ARBP

No data available

Company Profile & Key Executives for ARBP

Aurobindo Pharma Limited manufactures and markets oral and sterile antibiotics, antibacterials, anti-ulcerants and other generic basic drugs. Products include semi-synthetic penicillin drugs like ampicillin and amoxycillinas well as antibiotics, which include cloxacillin and dicloxacillin. The Company also manufactures formulations like astemizole, domeperidone and omeprazole.

K Nithyananda ReddyVice ChairmanN GovindarajanManaging Director
M Madan Mohan ReddyExecutive DirectorM SivakumaranExecutive Director
More Company Profile & Key Executives for ARBP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil